Prospective Multidisciplinary Post-COVID-19 Registry Tyrol

Last updated: September 16, 2022
Sponsor: Medical University Innsbruck
Overall Status: Active - Recruiting

Phase

N/A

Condition

Covid-19

Treatment

N/A

Clinical Study ID

NCT05545332
1450/2021_V2_10_02_2022
  • All Genders

Study Summary

Longitudinal, prospective observational cohort study enrolling patients with persisting symptoms (> 12 weeks) after COVID-19 in a multidisciplinary care model.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Individuals with persistent post COVID symptoms ≥ 12 weeks
  • post COVID functional status scale (PCFS) ≥ 2

Exclusion

Exclusion Criteria:

  • observation time after infection < 12 weeks
  • PCFS < 2

Study Design

Total Participants: 600
Study Start date:
March 03, 2022
Estimated Completion Date:
December 31, 2025

Study Description

Post-COVID-19 syndrome comprises a set of persistent physical, cognitive and/or psychological symptoms that continue for more than 12 weeks after illness and are not attributable to alternative diagnoses. As these symptoms may manifest in all COVID-19 severity grades, even in patients with mild or moderate disease, there is an urgent need for resource allocation in the health care system and accompanied research proposals to understand disease phenotypes and clinical trajectories.

With this prospective multidisciplinary registry, the investigators aim to establish a clinical and researchbased system by providing optimized medical diagnostic and therapeutic approaches in a model region in Austria (Tyrol).

Connect with a study center

  • Medical University of Innsbruck

    Innsbruck, 6020
    Austria

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.